• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 22, 2024 at 10:02: PM
via Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday.

article source
 




Top Bottom
Back
Quote